TriSalus Life Sciences Inc (TLSI) (Q3 2026) Earnings Call Highlights: Revenue Miss, TriNav ...
TriSalus Life Sciences Inc (TLSI) posted 11% revenue growth to $12.9 million but trimmed full-year 2026 guidance to $46-$48 million as new sales territories ramped slower than expected, while FDA Related Stocks: TLSI ,